| GTO ID | GTC2193 |
| Trial ID | NCT04099797 |
| Disease | Embryonal Cancer | High Grade Glioma | Ependymal Tumor |
| Altered gene | C7R|GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GD2.C7R T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) |
| Year | 2020 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-45668 GAIL-B |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||
|
|||||||||||||